Director's Note This issue of Milestones highlights some of our scientific advances in FY 2022-2023. Read More
Diving Below the Surface of Meningiomas A detailed molecular analysis reveals four subtypes of a common brain cancer. Read More
The Kiss of the Macrophage Breast cancer cells undergo dangerous reprogramming within passageways that connect tumors to the bloodstream. Read More
How T Cells See the World Artificial intelligence untangles the cellular signals that matter for anticancer immunity. Read More
A Red Flag for Immunotherapy A potential new marker for immunotherapy response could help guide treatment decisions. Read More
Bridging the Health Disparities Gap Aggressive breast and prostate cancers in African Americans have distinct molecular features. Read More
Predicting Resilience To fight cancer, T cells must first overcome a tumor’s hostile environment to reach their target. Read More
Narrowing the Search Elusive tumor-targeting T cells share a telltale gene activity signature. Read More
Seeing a Shape-Shifting Cancer Culprit The architectural details of a notorious cancer-promoting protein offer clues about how to keep it safely switched off. Read More
A Cancer Therapy for Everyone A simple approach using viral peptides shows efficacy against diverse tumor types in mice. Read More
New Faculty New faculty join CCR each year to contribute to our work of making breakthrough scientific discoveries to find cures and treatments for cancer. We also recognize current faculty who have started new roles within CCR. Read More
Awards & Honors We are proud of our CCR awardees who represent a spectacular array of accomplishments. Read More
By the Numbers Take a look at our year as told by the numbers to see a snapshot of the breakthrough scientific discoveries and important work happening at CCR. Read More